References
- Decker MD, Edwards KM. Pertussis (Whooping Cough). J Infect Dis. 2021;224(12 Suppl 2):S310-S320. doi:10.1093/infdis/jiaa469
- Trainor EA, Nicholson TL, Merkel TJ. Bordetella pertussis transmission. Pathog Dis. 2015;73(8):ftv068. doi:10.1093/femspd/ftv068
- Principi N, Bianchini S, Esposito S. Pertussis Epidemiology in Children: The Role of Maternal Immunization. Vaccines (Basel). 2024;12(9). doi:10.3390/vaccines12091030
- Zasztowt-Sternicka M, Jagielska AM, Nitsch-Osuch AS. Pertussis vaccination in pregnancy - current data on safety and effectiveness. Ginekol Pol. 2021;92(8):591-594. doi:10.5603/GP.a2021.0145
- Nieves DJ, Heininger U. Bordetella pertussis. Microbiol Spectr. 2016;4(3). doi:10.1128/microbiolspec. EI10-0008-2015
- World Health Organization. 32ND MEETING OF THE TECHNICAL ADVISORY GROUP ON IMMUNIZATION AND VACCINE-PREVENTABLE DISEASES IN THE WESTERN PACIFIC REGION.; 2023.
- World Health Organization. Pertussis (whooping cough). Accessed March 14, 2025. https://www.who. int/westernpacific/health-topics/pertussis#tab=tab_1
- Wang H, Fu M, Chen W, Ma Y. Post-COVID-19 pandemic changes in pertussis incidence among patients with acute respiratory tract infections in Zhejiang, China. Front Microbiol. 2024;15:1448997. doi:10.3389/fmicb.2024.1448997
- GOV.UK. Confirmed cases of pertussis in England by month, 2024. March 2025. Accessed March 14, 2025. https://www.gov.uk/government/publications/pertussis-epidemiology-in-england-2024/confirmed-cases-of-pertussis-in-england-by-month
- Zakład Epidemiologii Chorób Zakaźnych i Nadzoru NIZP PZH - PIB. Zachorowania Na Wybrane Choroby Zakaźne w Polsce Od 1 Stycznia Do 15 Września 2024 r. Oraz w Porównywalnym Okresie 2023 r.; 2024.
- Rumik A, Paradowska-Stankiewicz I, Rudowska J, Chrześcijańska I. Pertussis in Poland in 2016. Przegl Epidemiol. 2018;72(3):259-265. doi:10.32394/pe.72.3.1
- Jenkins VA, Savic M, Kandeil W. Pertussis in high-risk groups: an overview of the past quarter-century. Hum Vaccin Immunother. 2020;16(11):2609-2617. doi:10.1080/21645515.2020.1738168
- Cherry JD, and UHeininger. Pertussis and other Bordetella infections. In: Textbook of Pediatric Infectious Diseases. 5th ed. ; 2004.
- Robertson PW, Goldberg H, Jarvie BH, Smith DD, Whybin LR. Bordetella pertussis infection: a cause of persistent cough in adults. Medical Journal of Australia. 1987;146(10):522-525. doi:10.5694/j.1326-5377.1987. tb120392.x
- Heininger U, Cherry JD, Stehr K, et al. Comparative Efficacy of the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine and Lederle Whole-Cell Component DTP Vaccine in German Children After Household Exposure. Pediatrics. 1998;102(3):546-553. doi:10.1542/peds.102.3.546
- Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ. Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev. 2016;29(3):449-486. doi:10.1128/CMR.00083-15
- Edwards KM. Overview of Pertussis. Pediatr Infect Dis J. 2005;24(Supplement):S104-S108. doi:10.1097/01. inf.0000166154.47013.47
- Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326-382. doi:10.1128/CMR.18.2.326-382.2005
- Kwantes BW, Joynson DHM, Williams WO. Bordetella pertussis isolation in general practice: 1977–79 whooping cough epidemic in West Glamorgan. Journal of Hygiene. 1983;90(2):149-158. doi:10.1017/S0022172400028825
- Henry R, Dorman D, Skinner J, Mellis C. Limitations of erythromycin in whooping cough. Med J Aust. 1981;2(2):108-109. doi:10.5694/j.1326-5377.1981.tb100819.x
- van der Zee A, Schellekens JFP, Mooi FR. Laboratory Diagnosis of Pertussis. Clin Microbiol Rev. 2015;28(4):1005-1026. doi:10.1128/CMR.00031-15
- Tozzi AE, Celentano LP, Ciofi degli Atti ML, Salmaso S. Diagnosis and management of pertussis. CMAJ. 2005;172(4):509-515. doi:10.1503/cmaj.1040766
- Sylvia Yeh MdcMMM. Pertussis infection in infants and children: Clinical features and diagnosis. Up-ToDate. Published online 2016.
- Kretsinger K, Broder KR, Cortese MM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep. 2006;55(RR-17):1-37.
- Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev. 2007;2007(3):CD004404. doi:10.1002/14651858.CD004404.pub3
- Tiwari T, Murphy T V, Moran J, National Immunization Program C. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep. 2005;54(RR-14):1-16.
- Honein M, Paulozzi L, Himelright I, et al. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study. The Lancet. 1999;354(9196):2101-2105. doi:10.1016/S0140-6736(99)10073-4
- Cherry JD. Nosocomial Pertussis in the Nineties. Infect Control Hosp Epidemiol. 1995;16(10):553-555. doi:10.1086/647007
- Hoppe JE, Halm U, Hagedorn HJ, Kraminer-Hagedorn A. Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis. Infection. 1989;17(4):227-231. doi:10.1007/BF01639525
- Thampi N, Gurol-Urganci I, Crowcroft NS, Sander B. Pertussis post-exposure prophylaxis among household contacts: a cost-utility analysis. PLoS One. 2015;10(3):e0119271. doi:10.1371/journal.pone.0119271
- Wirsing von König CH, Postels-Multan S, Schmitt HJ, Bock HL. Pertussis in adults: frequency of transmission after household exposure. The Lancet. 1995;346(8986):1326-1329. doi:10.1016/S0140-6736(95)92343-8
- Cherry JD. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr. 1984;14(2):1-78. doi:10.1016/0045-9380(84)90016-1
- Cherry JD. “Pertussis vaccine encephalopathy”: it is time to recognize it as the myth that it is. JAMA. 263(12):1679-1680.
- Cody CL, Baraff LJ, Cherry JD, Marcy SM, Manclark CR. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics. 1981;68(5):650-660.
- Grimprel E, Bégué P, Anjak I, Njamkepo E, François P, Guiso N. Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France. Clinical Diagnostic Laboratory Immunology. 1996;3(1):93-97. doi:10.1128/cdli.3.1.93-97.1996
- Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children. New England Journal of Medicine. 2012;367(11):1012-1019. doi:10.1056/NEJMoa1200850
- Carlsson RM, von Segebaden K, Bergström J, Kling AM, Nilsson L. Surveillance of infant pertussis in Sweden 1998–2012; severity of disease in relation to the national vaccination programme. Eurosurveillance. 2015;20(6). doi:10.2807/1560-7917.ES2015.20.6.21032
- Tiwari T, Murphy T V, Moran J, National Immunization Program C. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep. 2005;54(RR-14):1-16.
- Główny Inspektor Sanitarny. Komunikat w Sprawie Programu Szczepień Ochronnych Na Rok 2024.; 2023.
- Brandon D, Kimmel M, Kuriyakose SO, Kostanyan L, Mesaros N. Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults. Vaccine. 2018;36(42):6325-6333. doi:10.1016/j.vaccine.2018.08.051
- Seppälä E, Bråthen Kristoffersen A, Bøås H, et al. Pertussis epidemiology including direct and indirect effects of the childhood pertussis booster vaccinations, Norway, 1998-2019. Vaccine. 2022;40(23):3142-3149. doi:10.1016/j.vaccine.2022.04.038
- Centers for Disease Control and Prevention. Pertussis Vaccination Recommendations.
- McNamara LA, Rubis AB, Pawloski L, et al. High post-exposure prophylaxis (PEP) uptake among household contacts of pertussis patients enrolled in a PEP effectiveness evaluation - United States, 20152017. PLoS One. 2023;18(5):e0285953. doi:10.1371/journal.pone.0285953